Displacement of submacular hemorrhage associated with age-related macular degeneration using vitrectomy and submacular tPA injection followed by intravitreal ranibizumab

References

• AveryRFekratSHawkinsBNatural history of subfoveal subretinal hemorrhage in age-related macular degenerationRetina1996161831898789855
   PubMed Web of Science ®Google Scholar
• BennettSRFolkJCBlodiCFFactors prognostic of visual outcome in patients with subretinal hemorrhageAm J Ophthalmol199010933372297030
   PubMed Web of Science ®Google Scholar
• ScupolaACoscosGSoubraneGNatural history of macular subretinal hemorrhage in age-related macular degenerationOphthalmologica1999213971029885385
   PubMed Web of Science ®Google Scholar
• ChenWLLiuJHLeeFLNatural course of submacular hemorrhageZhonghua Yi Xue Za Zhi Taipei199962526827710389281
   PubMedGoogle Scholar
• GlattHMachemerRExperimental subretinal hemorrhage in rabbitsAm J Ophthalmol1982947627737180915
   PubMed Web of Science ®Google Scholar
• TothCMorseLHjelmelandLFibrin directs early retinal damage after experimental subretinal hemorrhageArch Ophthalmol19911097237292025175
   PubMedGoogle Scholar
• BrownDMKaiserPKMichelsMANCHOR study group. Ranibizumab versus verteporfin for neovascular age-related macular degenerationN Engl J Med20063551432144417021319
   PubMed Web of Science ®Google Scholar
• RosenfieldPJBrownDMHeierJSMARINA study group. Ranibizumab for neovascular age-related macular degenerationN Engl J Med20063551419143117021318
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical Excellence: Pegaptanib and ranibizumab for the treatment of age-related macular degeneration. Available from: http://guidance.nice.org.uk/TA155 Accessed Sep 25, 2009.
   Google Scholar
• BresslerNMBresslerSBChildsALSubmacular Surgery Trials (SST) Research Group: surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings: SST report no. 13Ophthalmology20041111993200615522364
   PubMed Web of Science ®Google Scholar
• HeriotWIntravitreal gas and rtPA: an outpatient procedure for subretinal hemorrhageVail Vitrectomy Meeting199610–15 MarchVail, Colorado
   Google Scholar
• HesseLSchmidtJKrollPManagement of acute submacular hemorrhage using recombinant tissue plasminogen activator and gasGraefes Arch Clin Exp Ophthalmol1999237427327710208258
   PubMed Web of Science ®Google Scholar
• HassanASJohnsonMWSchneidermanTEManagement of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacementOphthalmology19991061019001906; discussion 1906190710519583
   PubMed Web of Science ®Google Scholar
• LincoffHKreissigIIntravitreal injection of tissue plasminogen activator and gas in subretinal hemorrhage caused by age-related macular degenerationRetina20012119111321154
   PubMed Web of Science ®Google Scholar
• SchulzeSDHesseLTissue plasminogen activator plus gas injection in patients with subretinal hemorrhage caused by age-related macular degeneration: predictive variables for visual outcomeGraefes Arch Clin Exp Ophthalmol200224071772012271367
   PubMed Web of Science ®Google Scholar
• KreplerKKrugerATittlMIntravitreal injection of tissue plasminogen activator and gas in subretinal hemorrhage caused by age-related macular degenerationRetina200020325125610872929
   PubMed Web of Science ®Google Scholar
• HattenbachLOKlaisCKochFHIntravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditionsOphthalmology200110881485149211470706
   PubMed Web of Science ®Google Scholar
• HaupertCLMcCuenBW2ndJaffeGJPars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degenerationAm J Ophthalmol2001131220821511228297
   PubMed Web of Science ®Google Scholar
• OlivierSChowDRPackoKHSubretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in age-related macular degenerationOphthalmology200411161201120815177972
   PubMed Web of Science ®Google Scholar
• MeyerCHSchollHPEterNCombined treatment of acute subretinal haemorrhages with intravitreal recombined tissue plasminogen activator, expansile gas and bevacizumab: a retrospective pilot studyActa Ophthalmol Scand2008865490494
   Google Scholar
• SacuSStifterEVécsei-MarlovitsPVManagement of extensive subfoveal haemorrhage secondary to neovascular age-related macular degenerationEye20092361404141018756282
   PubMed Web of Science ®Google Scholar
• HaslerPWLa CourMVillumsenJPnuematic displacement and intravitreal bevacizumab in the management of subretinal haemorrhage caused by choroidal neovascularizationActa Ophthalmol Scand20078557757817559558
   PubMedGoogle Scholar
• The Royal College of Ophthalmologists Ranibizumab: the clinician’s guide to commencing, continuing and discontinuing treatment. Available from: http://www.rcophth.ac.uk/docs/scientific/Ranibizumab_June_2008.pdf Accessed on Sep 25, 2009.
   Google Scholar
• PolinerLSOikRJBurgessDNatural history of retinal pigment epithelial detachments in age-related macular degenerationOphthalmology19869355435512425324
   PubMed Web of Science ®Google Scholar
• BaetemanCHoffartLGallandFSubretinal hemorrhage after intravitreal injection of anti-VEGF for age-related macular degeneration: a retrospective studyJ Fr Ophtalmol200932530931319769866
   PubMed Web of Science ®Google Scholar
• GoverdhanSVLochheadJSubmacular haemorrhages after intravitreal bevacizumab for large occult choroidal neovascularisation in age-related macular degenerationBr J Ophthalmol200992221021217965104
   PubMed Web of Science ®Google Scholar
• LincoffHKreissigIStopaMUramDA 40 degrees gaze down position for pneumatic displacement of submacular hemorrhage: clinical application and resultsRetina2008281565918185138
   PubMed Web of Science ®Google Scholar
• KameiMMisonoKLewisHA study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbitsAm J Ophthalmol1999128673974610612511
   PubMed Web of Science ®Google Scholar
• LewisHIntraoperative fibrinolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainageAm J Ophthalmol199411855595687977569
   PubMed Web of Science ®Google Scholar
• HillenkampJSurguchVFrammeCManagement of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activatorGraefes Arch Clin Exp Ophthalmol Epub 2009 Aug 11.
   Web of Science ®Google Scholar
• LeeSJLeeCSKohHJPosterior vitreomacular adhesion and risk of exudative age-related macular degeneration: paired eye studyAm J Ophthalmol20091474621.e1626.e119159862
   PubMed Web of Science ®Google Scholar
• MojanaFChengLBartschDUThe role of abnormal vitreomacular adhesion in age-related macular degeneration: spectral optical coherence tomography and surgical resultsAm J Ophthalmol2008146221822718538742
   PubMed Web of Science ®Google Scholar
• StefánssonEPhysiology of vitreous surgeryGraefes Arch Clin Exp Ophthalmol2009247214716319034481
   PubMed Web of Science ®Google Scholar
• WilliamsonTHGrewalJGuptaBMeasurement of PO2 during vitrectomy for central retinal vein occlusion, a pilot studyGraefes Arch Clin Exp Ophthalmol200924781019102319347349
   PubMed Web of Science ®Google Scholar
• ChinHSParkTSMoonYSOhJHDifference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyesRetina200525555656016077349
   PubMed Web of Science ®Google Scholar
• DoftBHWeiskopfJNilsson-EhleIWingardLBJrAmphotericin clearance in vitrectomized versus nonvitrectomized eyesOphthalmology19859211160116053878487
   PubMed Web of Science ®Google Scholar
• TreumerFKlattCRoiderJHillenkampJSubretinal co-application of recombinant tissue plasminogen activator and bevacizumab for neovascular age-related macular degeneration with submacular hemorrhageBr J Ophthalmol Epub 2009 Nov 27.
   Google Scholar
• KrishnanRGoverdhanSLochheadJSubmacular haemorrhage after intravitreal bevacizumab compared with intravitreal ranibizumab in large occult choroidal neovascularizationClin Experiment Ophthalmol200937438438819594565
   PubMed Web of Science ®Google Scholar
• KaragiannisDAMitropoulosPLadasIDLarge subretinal haemorrhage following change from intravitreal bevacizumab to ranibizumabOphthalmologica2009223427928219390227
   PubMed Web of Science ®Google Scholar
• ChenCYHooperCChiuDManagement of submacular hemorrhage with intravitreal injection of tissue plasminogen activator and expansile gasRetina200727332132817460587
   PubMed Web of Science ®Google Scholar
• VoteBJButteryRPolkinhornePJEndophthalmitis after intravitreal injection of frozen prepared tissue activator (tPA) for pneumatic displacement of submacular hemorrhageRetina200020325125610872929
   PubMed Web of Science ®Google Scholar
• MaliRSChengMChintalaSKPlasminogen activators promote excitotoxicity-induced retinal damageFASEB J200519101280128916051695
   PubMed Web of Science ®Google Scholar
• ChenSNYangTCHoCLRetinal toxicity of intravitreal tissue plasminogen activator: case report and literature reviewOphthalmology2003110470470812689889
   PubMed Web of Science ®Google Scholar
• SolimanWLund-AndersonHLarsenMResolution of subretinal haemorrhage and fluid after bevacizumab in aggressive peripapillary subretinal neovascularizationActa Ophthalmol Scand20068470770816965507
   PubMedGoogle Scholar
• StifterEMichelsSPragerFIntravitreal bevacizumab therapy for neovascular age-related macular degeneration with large submacular hemorrhageAm J Ophthalmol2007144688689217916314
   PubMed Web of Science ®Google Scholar